RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 45-55
  • Arrowhead Research seeks to reassure antsy investors

    Arrowhead Research seeks to reassure antsy investors
    Arrowhead Research Corp. is trying to succeed where major pharmaceutical company efforts have failed in finding a cure for one of the world's most tenacious diseases. The Pasadena biopharmaceutical company is developing so-called RNAi therapeutics. Such...
  • Local company develops training products for self-injection

    Local company develops training products for self-injection
    Twenty years ago Jeff Baker started a promotional product company in a spare bedroom in his home in Indianapolis. Today, that business, called Noble, has turned into a privately held multimillion-dollar niche product manufacturing company that takes...
  • Allergan sale to Actavis thwarts takeover attempt by Valeant

    Botox maker Allergan Inc., an Irvine company that started as a purveyor of eye drops and grew into one of the most respected pharmaceutical companies in the country, agreed to be acquired by Irish firm Actavis for $66 billion. The deal thwarts a...
  • Ingredion predicts $8 billion in sales by 2019

     Ingredion predicts $8 billion in sales by 2019
    Ingredion said Tuesday its annual sales should hit $8 billion by 2019, up from $6.33 billion last year, as the ingredients-maker pushes to notch more sales from fast-growing specialty products and international markets. The announcement comes weeks after...
  • Allergan says a 2nd suitor wants to buy it, adding to takeover drama

    Allergan says a 2nd suitor wants to buy it, adding to takeover drama
    Botox maker Allergan Inc., which has been fighting an unsolicited takeover bid from a Canadian pharmaceutical maker for six months, said in a regulatory filing that a second company is interested in buying it. Allergan did not identify the new...
  • Oklahoma Supreme Court puts abortion restriction on hold

    The Oklahoma Supreme Court on Tuesday temporarily put on hold a state law restricting abortions while the issue is argued in a lower court. The unanimous action by the high court means that women in Oklahoma can continue to use the prescription drugs...
  • Allergan loses bid to block Ackman from voting on takeover

    Allergan loses bid to block Ackman from voting on takeover
    Botox maker Allergan Inc. lost its bid to prohibit activist investor Bill Ackman's hedge fund from voting in a shareholder election that could decide a hotly contested takeover effort. Allergan had accused Ackman's Pershing Square Capital Management...
  • OraSure expects milestones in its Ebola research

    OraSure expects milestones in its Ebola research
    By the end of the year, Bethlehem-based OraSure expects to announce key research milestones in determining if its OraQuick rapid in-home HIV test can be adapted to screen patients for Ebola. The company has consulted with the federal Food and Drug...
  • A balloon for obesity: an option between medication and surgery?

    A balloon for obesity: an option between medication and surgery?
    For many struggling with obesity, taking one of the newly approved prescription medications for weight loss (marketed as Qsymia, Belviq and Contrave) feels like climbing a mountain with a walking cane — it's a little help, but not enough. And...
  • Allergan, fighting off Valeant, discussing merger with another firm

    Allergan, fighting off Valeant, discussing merger with another firm
    Botox maker Allergan Inc. said it’s discussing a merger with an unnamed firm as it battles a hostile takeover by Valeant Pharmaceuticals. For six months Irvine-based Allergan has fought off an unsolicited takeover bid from Valeant...
  • AbbVie board calls off Shire acquisition

    AbbVie board calls off Shire acquisition
    North Chicago-based drugmaker AbbVie has pulled the plug on its plan to buy Dublin-based Shire, recommending shareholders vote against the planned $55 billion takeover following new U.S. tax rules. Shire stands to be paid a break-up fee of about $1.64...